Skip to main content
European Commission logo
Public Health

Joint Clinical Assessment report on tovorafenib (Ojemda)

  • Background document

Details

Publication date
9 June 2026
Author
Directorate-General for Health and Food Safety

Description

JCA report on tovorafenib (Ojemda):

Date of endorsement by the Member State Coordination Group on HTA: 30 April 2026

Date of conclusion of the procedural review by the European Commission: 19 May 2026

 

Additional files:

Files

  • 9 JUNE 2026
hta_jca_mp_202406_tovorafenib_summary-report_en
  • 9 JUNE 2026
hta_jca_mp_202406_tovorafenib_report_en
  • 9 JUNE 2026
hta_jca_mp_202406_tovorafenib_dossier_en
  • 9 JUNE 2026
hta_jca_mp_202406_tovorafenib_annex_htd_accuracy_check_en